Search Results - "Shokat, K.M"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Chemically targeting the PI3K family by Knight, Z A, Shokat, K M

    Published in Biochemical Society transactions (01-04-2007)
    “…PI3K (phosphoinositide 3-kinase) is a key regulator of cell growth, metabolism and survival. The frequent activation of the PI3K pathway in cancer has…”
    Get more information
    Journal Article
  2. 2
  3. 3

    Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors by Ducker, G S, Atreya, C E, Simko, J P, Hom, Y K, Matli, M R, Benes, C H, Hann, B, Nakakura, E K, Bergsland, E K, Donner, D B, Settleman, J, Shokat, K M, Warren, R S

    Published in Oncogene (20-03-2014)
    “…The mammalian target of rapamycin (mTOR) regulates cell growth by integrating nutrient and growth factor signaling and is strongly implicated in cancer. But…”
    Get full text
    Journal Article
  4. 4

    PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML by Park, S, Chapuis, N, Bardet, V, Tamburini, J, Gallay, N, Willems, L, Knight, Z A, Shokat, K M, Azar, N, Viguié, F, Ifrah, N, Dreyfus, F, Mayeux, P, Lacombe, C, Bouscary, D

    Published in Leukemia (01-09-2008)
    “…The phosphatidylinositol 3-kinase (PI3K)/Akt and mammalian target of rapamycin complex 1 (mTORC1) signaling pathways are frequently activated in acute…”
    Get full text
    Journal Article
  5. 5

    Bio-orthogonal Affinity Purification of Direct Kinase Substrates by Allen, Jasmina J, Lazerwith, Scott E, Shokat, Kevan M

    Published in Journal of the American Chemical Society (20-04-2005)
    “…Protein phosphorylation is a major mechanism of post-translational protein modification used to control cellular signaling. A challenge in phosphoproteomics is…”
    Get full text
    Journal Article
  6. 6

    A molecular gate which controls unnatural ATP analogue recognition by the tyrosine kinase v-Src by Liu, Y., Shah, K., Yang, F., Witucki, L., Shokat, K.M.

    Published in Bioorganic & medicinal chemistry (01-08-1998)
    “…Engineered proteins with specificity for unnatural substrates or ligands are useful tools for studying or manipulating complex biological systems. We have…”
    Get full text
    Journal Article
  7. 7

    Chemical genomic profiling to identify intracellular targets of a multiplex kinase inhibitor by Kung, C, Kenski, D.M, Dickerson, S.H, Howson, R.W, Kuyper, L.F, Madhani, H.D, Shokat, K.M

    “…The identification of the kinase or kinases targeted by protein kinase inhibitors is a critical challenge in validating their use as therapeutic agents or…”
    Get full text
    Journal Article
  8. 8

    A new strategy for the generation of catalytic antibodies by Shokat, K. M, Leumann, C. J, Sugasawara, R, Schultz, P. G

    Published in Nature (London) (16-03-1989)
    “…The high binding affinity and specificity of antibodies for a wide range of ligands has recently been exploited in the generation of catalysts for…”
    Get full text
    Journal Article